Literature DB >> 16105192

Impact of an effective multidrug-resistant tuberculosis control programme in the setting of an immature HIV epidemic: system dynamics simulation model.

Rifat A Atun1, Reda Lebcir, Francis Drobniewski, Richard J Coker.   

Abstract

This study sought to determine the impact of an effective programme of multidrug resistant tuberculosis control (MDRTB) on a population that is witnessing an explosive HIV epidemic among injecting drug users (IDUs), where the prevalence of MDRTB is already high. A transmission model was constructed that represents the dynamics of the drug-susceptible tuberculosis (DSTB), MDRTB and HIV spread among the adult population of Samara Oblast, Russia: from official notifications of tuberculosis and of HIV infection, estimates of MDRTB derived from surveillance studies, population data from official regional statistics, data on transmission probabilities from peer-reviewed publications and informed estimates, and policy-makers' estimates of IDU populations. Two scenarios of programme effectiveness for MDRTB were modelled and run over a period of 10 years to predict cumulative deaths. In a population of 3.3 million with a high prevalence of MDRTB, an emerging epidemic of HIV among IDUs, and a functioning directly observed therapy-short course (DOTS) programme, the model predicts that under low cure rates for MDRTB the expected cumulative deaths from tuberculosis will reach 6303 deaths including 1900 deaths from MDRTB at 10 years. Under high cure rate for MDRTB 4465 deaths will occur including 134 deaths from MDRTB. At 10 years there is little impact on HIV-infected populations from the MDRTB epidemic, but as the HIV epidemic matures the impact becomes substantial. When the model is extended to 20 years cumulative deaths from MDRTB become very high if cure rates for MDRTB are low and cumulative deaths in the HIV-infected population, likewise, are profoundly affected. In the presence of an immature HIV epidemic failure to actively control MDRTB may result in approximately a third more deaths than if effective treatment is given. As the HIV epidemic matures then the impact of MDRTB grows substantially if MDRTB control strategies are ineffective. The epidemiological starting point for these scenarios is present in many regions within the former Soviet Union and this analysis suggests control of MDRTB should be an urgent priority.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16105192     DOI: 10.1258/0956462054679124

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  12 in total

Review 1.  The rising impact of mathematical modelling in epidemiology: antibiotic resistance research as a case study.

Authors:  L Temime; G Hejblum; M Setbon; A J Valleron
Journal:  Epidemiol Infect       Date:  2007-09-04       Impact factor: 2.451

2.  Modeling the joint epidemics of TB and HIV in a South African township.

Authors:  Nicolas Bacaër; Rachid Ouifki; Carel Pretorius; Robin Wood; Brian Williams
Journal:  J Math Biol       Date:  2008-04-15       Impact factor: 2.259

3.  Evaluation of two molecular assays for rapid detection of mycobacterium tuberculosis resistance to fluoroquinolones in high-tuberculosis and -multidrug-resistance Settings.

Authors:  I Kontsevaya; S Mironova; V Nikolayevskyy; Y Balabanova; S Mitchell; F Drobniewski
Journal:  J Clin Microbiol       Date:  2011-06-01       Impact factor: 5.948

4.  Modeling the dynamic relationship between HIV and the risk of drug-resistant tuberculosis.

Authors:  Rinat Sergeev; Caroline Colijn; Megan Murray; Ted Cohen
Journal:  Sci Transl Med       Date:  2012-05-23       Impact factor: 17.956

5.  Impact of Therapy on Recovery during Rehabilitation in Patients with Traumatic Spinal Cord Injury.

Authors:  Catherine Truchon; Nader Fallah; Argelio Santos; Joëlle Vachon; Vanessa K Noonan; Christiana L Cheng
Journal:  J Neurotrauma       Date:  2017-06-26       Impact factor: 5.269

Review 6.  Resistance to implementing policy change: the case of Ukraine.

Authors:  Rifat Atun; Igor Olynik
Journal:  Bull World Health Organ       Date:  2008-02       Impact factor: 9.408

7.  Controlling Co-Epidemics: Analysis of HIV and Tuberculosis Infection Dynamics.

Authors:  Elisa F Long; Naveen K Vaidya; Margaret L Brandeau
Journal:  Oper Res       Date:  2008       Impact factor: 3.310

8.  Direct Detection by the Xpert MTB/RIF Assay and Characterization of Multi and Poly Drug-Resistant Tuberculosis in Guinea-Bissau, West Africa.

Authors:  Paulo Rabna; Jorge Ramos; Gema Ponce; Lilica Sanca; Morto Mané; Ana Armada; Diana Machado; Fina Vieira; Victor F Gomes; Elisabete Martins; Raffaella Colombatti; Fabio Riccardi; João Perdigão; Joana Sotero; Isabel Portugal; Isabel Couto; Jorge Atouguia; Amabélia Rodrigues; Miguel Viveiros
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240

9.  Performance of the Genotype MTBDRPlus assay in the diagnosis of tuberculosis and drug resistance in Samara, Russian Federation.

Authors:  Vladyslav Nikolayevskyy; Yanina Balabanova; Tatyana Simak; Nadezhda Malomanova; Ivan Fedorin; Francis Drobniewski
Journal:  BMC Clin Pathol       Date:  2009-03-10

Review 10.  A modeling framework for the evolution and spread of antibiotic resistance: literature review and model categorization.

Authors:  Ian H Spicknall; Betsy Foxman; Carl F Marrs; Joseph N S Eisenberg
Journal:  Am J Epidemiol       Date:  2013-05-09       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.